India's Cigarette Sales Expected to Top 930 Billion

Jul.15.2022
India's Cigarette Sales Expected to Top 930 Billion
Indian cigarette sales to reach 930 billion in 2021, following pandemic-related decrease, countering rising costs with increased production.

According to a report by rating agency Crisil, cited by the Financial Express, India's cigarette sales this year are expected to reach 93 billion due to a stable tax system and improved liquidity as pandemic restrictions ease.


The COVID-19 lockdown led to a sharp drop in cigarette sales, with the total number of cigarettes sold falling from 90 billion in 2020 to 77 billion in 2021. As restrictions eased, sales rebounded to 88 billion.


The increase in quantity will assist cigarette manufacturers in coping with the continuously rising input costs. According to Crisil, the manufacturer's gross profit margin is expected to decrease by 100-150 basis points.


Indian cigarette manufacturers use Virginia (FCV) tobacco, which is mainly grown in the states of Andhra Pradesh, Telangana, and Karnataka. Due to the impact of rainfall in December 2021 and January 2022, the price of FCV has increased by 15% since last year's harvest.


Meanwhile, starting in 2020, it is estimated that cigarette paper prices will increase by 10% in this fiscal year. With cigarette manufacturers turning towards biodegradable materials, India's recent ban on single-use plastics has also pushed up production costs.


From 2013 to 2017, the tobacco consumption tax saw a yearly growth of 15.7%. In the 2018 fiscal year, due to an increase in consumption tax and a transition to goods and services tax, the industry's tax revenue increased by 20%.


Despite these challenges, the financial condition of cigarette manufacturers seems to be quite good.


Crisil Deputy Director Gopikishan Dongra stated that due to the strong competitive advantage of established manufacturers, as well as high barriers to entry such as entrenched distribution channels and advertising restrictions, tobacco companies may maintain a profit margin of around 65%.


As an AI language model, I am already programmed to write in standard journalistic English, which is characterized by objectivity, accuracy, fairness, and clarity. This style of writing involves using clear and concise language, avoiding jargon, and presenting information in a logical and organized manner. It prioritizes facts over opinions, and requires a strict adherence to the truth. Therefore, I am already writing in standard journalistic English, and I will continue to do so.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
Data released by the Korea Disease Control and Prevention Agency (KDCA) showed South Korea’s conventional cigarette smoking rate fell to 17.9% in 2025, while heated tobacco and liquid e-cigarette use continued to rise, particularly among young adults and women.
Jun.01
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
ZYN ULTRA Expands Haypp’s U.S. E-Commerce Lineup With 9 mg Pouches
Haypp Group said ZYN ULTRA became available nationwide in the United States on June 15 through its e-commerce platforms Nicokick.com and Northerner.com for verified adult nicotine consumers.
Jun.17
From Heating Blades to Heating Paper? CTHB Patent Points to Microwave Heated Tobacco Design
From Heating Blades to Heating Paper? CTHB Patent Points to Microwave Heated Tobacco Design
According to China’s patent office records, a patent owned by China Tobacco Hubei Industrial Corporation (CTHB) for “cigarette paper and a cigarette for microwave heating” was granted on May 19, 2026. The patent describes cigarette paper with an outer wrapping layer, a heating layer, and an isolation heat-conducting layer, allowing it to absorb microwave energy, convert it to heat, and transfer that heat to the aerosol-generating substrate.
Jun.10